Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

m-phasys GmbH

m-phasys was established in 1999 as a university spin-off. The private venture capital-backed company is based in Tübingen within easy reach of the international airport at Stuttgart. The M-FOLD™ technology for the production of purified, functional membrane proteins is the basis of m-phasys' activities. Since operations started, this platform has been gradually expanded to new target families and transformed into a miniaturized, parallel format. The company, originally focused on the structure analysis of membrane proteins alone, recently added the generation of therapeutic GPCR antibodies to its business areas.


Contact Details:
Vor dem Kreuzberg 17
Tübingen
D - 72070
Germany
Tel:49-7071-7945-0
Fax:49-7071-7945-11
Email:contact@m-phasys.com
WWW:

www.m-phasys.com/




Recent Publications by m-phasys GmbH:

In vitro folding of alpha-helical membrane proteins.
For large-scale production, as required in structural biology, membrane...
5th June, 2003
m-phasys GmbH, Vor dem Kreuzberg 17, D-72070 Tubingen, Germany. Biochim Biophys Acta. 2003 Feb 17;1610(1):57-62.

Press Releases on m-phasys GmbH:

BioPortfolio Logo
Cytomyx signs major new contract with m-phasys 1st May, 2002 Cytomyx
  Cytomyx signs major new contract with m-phasys 27th May 2002, Cambridge, UK – Cytomyx (AIM: CYX), the Discovery Research
CENIX BIOSCIENCE, A PIONEER IN RNAi TECHNOLOGIES, RAISES Euros 5 MILLION 1st January, 1970 Cenix
CENIX BIOSCIENCE, A PIONEER IN RNAi TECHNOLOGIES, RAISES € 5 MILLION IN INTERNATIONAL FINANCING ROUND Dresden, Germany, 10th September, 2002 - Cenix

BioNews Results for m-phasys GmbH:

Bernhard Hampl, Ph.D. Elected to Serve as Executive Chairman of the Board of Directors of Fresenius Kabi Pharm
Pharma Live:  Nov 5 2009 4:58PM Matching: m gmbh
Bernhard Hampl, Ph.D. Elected to Serve as Executive Chairman of the Board of Directors of Fresenius Kabi Pharm
Pharmacy Choice:  Nov 3 2009 9:14AM Matching: m gmbh
Bernhard Hampl, Ph.D. Elected to Serve As Executive Chairman of the Board of Directors of Fresenius Kabi Pharmaceuticals Holding, Inc.
I Stock Analyst:  Nov 3 2009 6:36AM Matching: m gmbh
Bernhard Hampl, Ph.D. Elected to Serve as Executive Chairman of the Board of Directors of Fresenius Kabi Pharm
Genetic Engineering News:  Nov 3 2009 2:22AM Matching: m gmbh
Bernhard Hampl, Ph.D. Elected to Serve as Executive Chairman of the Board of Directors of Fresenius Kabi Pharmaceuticals Holding, Inc.
Earthtimes.org:  Nov 3 2009 12:50AM Matching: m gmbh
Promote your company here: BioNewsCast - Press Release Distribution

View more m-phasys GmbH news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 229 times since April 2007, the link to the organisation's website has been followed 60 times

Search for more companies in Tübingen

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for m-phasys GmbH

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.